RxDoctor Payments Data

Ryan Vincent

Pain Medicine · Oklahoma City, OKNPI 1376986604

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,769 of the $7,492 with a category attached, or 63.7%. 27 manufacturers reported payments, led by Abbott at 32.9% of the total. Reporting peaked in 2019 at $3,866 and has fallen 84.9% since, to $585 in 2025.

$7,492in general payments, 2019–2025

Across 156 payments — averaging $48.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • Nevro Corp.$1K
  • Vertiflex, Inc.$845
  • Boston Scientific$802
  • Pacira Pharmaceuticals Incorporated$769
  • Medtronic$300
  • plus $1K from 21 others

What the payments were for

  • Travel & lodging$2,42032%
  • Food & beverage$4,76964%
  • Education$3034%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,492 in reported general payments places this provider in the 70th percentile of 68 pain medicine providers in Oklahoma.

See all pain medicine providers in Oklahoma

Medicare billing

Part B allowed, 2024
$315,324
Medicare patients
292
Services billed
19,248

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen631$17,830
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen299$11,824
MovantikNaloxegol Oxalate11$4,151
Pregabalin200$3,729
Gabapentin252$3,685
Buprenorphine12$1,876
Tramadol Hcl202$1,594
Naloxone Hcl20$1,101
Tizanidine Hcl71$943
Morphine Sulfate13$785
Methylprednisolone91$779
Oxycodone Hcl41$762
Methocarbamol27$637
Acetaminophen-CodeineAcetaminophen With Codeine49$628
Fentanyl12$562

Paid to pharmacies, not to this prescriber.

Other pain medicine in Oklahoma City

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →